While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback